410 related articles for article (PubMed ID: 27061389)
21. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.
Elkington R; Walker S; Crough T; Menzies M; Tellam J; Bharadwaj M; Khanna R
J Virol; 2003 May; 77(9):5226-40. PubMed ID: 12692225
[TBL] [Abstract][Full Text] [Related]
22. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
[TBL] [Abstract][Full Text] [Related]
23. Evolution of human cytomegalovirus-seronegative donor/-seropositive recipient high-risk combination frequency in allogeneic hematopoietic stem cell transplantations at Institute of Hematology and Blood Transfusion during 1995-2014.
Nemeckova S; Sroller V; Stastna-Markova M
Transpl Infect Dis; 2016 Apr; 18(2):297-301. PubMed ID: 26858009
[TBL] [Abstract][Full Text] [Related]
24. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.
Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G
Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371
[TBL] [Abstract][Full Text] [Related]
25. Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients.
Zavaglio F; Vitello D; Bergami F; Arena F; Borsani O; Colombo AA; Caldera D; Lilleri D; Cassaniti I; Bernasconi P; Baldanti F
J Clin Virol; 2023 Aug; 165():105519. PubMed ID: 37321150
[TBL] [Abstract][Full Text] [Related]
26. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.
Gratama JW; van Esser JW; Lamers CH; Tournay C; Löwenberg B; Bolhuis RL; Cornelissen JJ
Blood; 2001 Sep; 98(5):1358-64. PubMed ID: 11520783
[TBL] [Abstract][Full Text] [Related]
27. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
28. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
[TBL] [Abstract][Full Text] [Related]
29. Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.
Krawczyk A; Ackermann J; Goitowski B; Trenschel R; Ditschkowski M; Timm J; Ottinger H; Beelen DW; Grüner N; Fiedler M
J Clin Virol; 2018; 99-100():61-66. PubMed ID: 29331844
[TBL] [Abstract][Full Text] [Related]
30. Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells.
Jackson SE; Mason GM; Okecha G; Sissons JG; Wills MR
J Virol; 2014 Sep; 88(18):10894-908. PubMed ID: 25008941
[TBL] [Abstract][Full Text] [Related]
31. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
Giménez E; Muñoz-Cobo B; Solano C; Amat P; de la Cámara R; Nieto J; López J; Remigia MJ; Garcia-Noblejas A; Navarro D
Transpl Infect Dis; 2015 Jun; 17(3):361-70. PubMed ID: 25850900
[TBL] [Abstract][Full Text] [Related]
32. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.
Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; López J; Garcia-Noblejas A; Muñoz-Cobo B; Costa E; Clari MA; Hernández-Boluda JC; Remigia MJ; Navarro D
Bone Marrow Transplant; 2011 Nov; 46(11):1437-43. PubMed ID: 21243030
[TBL] [Abstract][Full Text] [Related]
33. Relationship between T-cell receptor beta chain sequences and human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
Wu Z; Zhang H; Jin M; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Fan J
Mol Med Rep; 2017 Jun; 15(6):3898-3904. PubMed ID: 28440401
[TBL] [Abstract][Full Text] [Related]
34. Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.
Yong MK; Cameron PU; Slavin M; Morrissey CO; Bergin K; Spencer A; Ritchie D; Cheng AC; Samri A; Carcelain G; Autran B; Lewin SR
J Infect Dis; 2017 Jun; 215(11):1684-1694. PubMed ID: 28431019
[TBL] [Abstract][Full Text] [Related]
35. Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients.
Lilleri D; Zelini P; Fornara C; Comolli G; Gerna G
Am J Transplant; 2007 Aug; 7(8):1997-2005. PubMed ID: 17617865
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
Eid AJ; Brown RA; Hogan WJ; Lahr BD; Eckel-Passow JE; Litzow MR; Razonable RR
Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286
[TBL] [Abstract][Full Text] [Related]
37. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.
Sacre K; Carcelain G; Cassoux N; Fillet AM; Costagliola D; Vittecoq D; Salmon D; Amoura Z; Katlama C; Autran B
J Exp Med; 2005 Jun; 201(12):1999-2010. PubMed ID: 15967826
[TBL] [Abstract][Full Text] [Related]
38. Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.
Sacre K; Nguyen S; Deback C; Carcelain G; Vernant JP; Leblond V; Autran B; Dhedin N
J Virol; 2008 Oct; 82(20):10143-52. PubMed ID: 18684826
[TBL] [Abstract][Full Text] [Related]
39. Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.
Lilleri D; Gerna G; Fornara C; Chiesa A; Comolli G; Zecca M; Locatelli F
J Infect Dis; 2009 Mar; 199(6):829-36. PubMed ID: 19239337
[TBL] [Abstract][Full Text] [Related]
40. ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients.
Zavaglio F; Rivela F; Cassaniti I; Arena F; Gabanti E; Asti AL; Lilleri D; Rampino T; Baldanti F; Gregorini M
J Med Virol; 2023 Feb; 95(2):e28507. PubMed ID: 36655741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]